PSC
ABVX

Patient Square Capital’s Abivax ABVX Stock Holding History

Patient Square Capital’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.5M Buy
206,500
+85,255
+70% +$9.65M 4.26% 4
2026
Q1 		$13.5M Sell
121,245
-8,755
-7% -$1.04M 2.4% 12
2025
Q4 		$17.5M Sell
130,000
-21,833
-14% -$2.38M 3.75% 6
2025
Q3 		$12.9M Buy
+151,833
New +$9.31M 3.45% 4

Other funds holding ABVX

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
HI
Helikon Investments London, United Kingdom $3.35B AUM 55.08% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Patient Square Capital's ABVX Position: Q2 2026 in Review

Patient Square Capital increased its Abivax (ABVX) stake by 70% in Q2 2026, buying an estimated $9.65M and bringing the position to 206,500 shares worth $27.5M. The position accounts for 4.26% of the portfolio, ranked #4.

Patient Square Capital first reported a position in ABVX in Q3 2025 and has held it in 4 quarters since. 303 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

  • Patient Square Capital held 206,500 shares of Abivax worth $27.5M as of Q2 2026.
  • Patient Square Capital bought 85,255 Abivax shares in Q2 2026, an estimated $9.65M.
  • Abivax made up 4.26% of Patient Square Capital's portfolio in Q2 2026, its #4 holding.
  • Patient Square Capital first reported a position in Abivax in Q3 2025 and has held it in 4 quarters since.
  • 303 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on Patient Square Capital's 13F filing for Q2 2026, filed 12 Aug 2026.